September 13, 2019Science Immunology122 citationsOpen Access

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

SASita Awasthi LHLauren M. Hook NPNorbert Pardi

Key Points

Key points are not available for this paper at this time.

Abstract

T cell responses, and T follicular helper and germinal center B cell responses. The trivalent nucleoside-modified mRNA-LNP vaccine is a promising candidate for human trials.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Awasthi et al. (Fri,) studied this question.

synapsesocial.com/papers/6a45e41ac669e74762d0acde https://doi.org/https://doi.org/10.1126/sciimmunol.aaw7083

Demander à l'IA

Bookmark

View Full Paper